Subscribe To
MRK / Merck's Profit Beats Estimates on Sales of Its Cancer, COVID-19 Drugs and HPV Shot
![Merck's Profit Beats Estimates on Sales of Its Cancer, COVID-19 Drugs and HPV Shot](https://cdn.snapi.dev/images/v1/7/d/gettyimages-1236361876-406949f3e69b4f9cbb6064c4efb952f3-2124300.jpg)
MRK News
![Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now? Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?](https://cdn.snapi.dev/images/v1/p/m/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f7526652fscientist-peers-in-microscope-in-labjpgopresizew400h400-2130615.jpg)
By The Motley Fool
October 31, 2023
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now?
Merck and Daiichi Sankyo just signed a multibillion-dollar drug collaboration. The pair will work to develop three medicines to eventually replace Key more_horizontal
![BMO Capital upgrades Merck to 'outperform' BMO Capital upgrades Merck to 'outperform'](https://cdn.snapi.dev/images/v1/v/g/vgr3rf-2126369.jpg)
By CNBC Television
October 27, 2023
BMO Capital upgrades Merck to 'outperform'
BMO has upgraded Merck to outperform from market perform. more_horizontal
![Merck's Profit Beats Estimates on Sales of Its Cancer, COVID-19 Drugs and HPV Shot Merck's Profit Beats Estimates on Sales of Its Cancer, COVID-19 Drugs and HPV Shot](https://cdn.snapi.dev/images/v1/7/d/gettyimages-1236361876-406949f3e69b4f9cbb6064c4efb952f3-2124300.jpg)
By Investopedia
October 26, 2023
Merck's Profit Beats Estimates on Sales of Its Cancer, COVID-19 Drugs and HPV Shot
Merck (MRK) posted better-than-expected results on strong sales of its popular Keytruda cancer drug and HPV vaccine Gardasil, as well as a jump in dem more_horizontal
![Merck & Co., Inc. (MRK) Q3 2023 Earnings Call Transcript Merck & Co., Inc. (MRK) Q3 2023 Earnings Call Transcript](https://cdn.snapi.dev/images/v1/b/v/transcript14-2123944.jpg)
By Seeking Alpha
October 26, 2023
Merck & Co., Inc. (MRK) Q3 2023 Earnings Call Transcript
Merck & Co., Inc. (NYSE:MRK ) Q3 2023 Earnings Conference Call October 26, 2023 9:00 AM ET Company Participants Peter Dannenbaum - Vice President, Inv more_horizontal
![Merck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales Merck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales](https://cdn.snapi.dev/images/v1/s/7/2483-2123708.jpg)
By Zacks Investment Research
October 26, 2023
Merck (MRK) Q3 Earnings Top Estimates, COVID Drug Boosts Sales
Merck (MRK) beats Q3 estimates for earnings and sales. It raises its 2023 guidance. more_horizontal
![Merck (MRK) Q3 Earnings and Revenues Beat Estimates Merck (MRK) Q3 Earnings and Revenues Beat Estimates](https://cdn.snapi.dev/images/v1/n/1/default18-2122716.jpg)
By Zacks Investment Research
October 26, 2023
Merck (MRK) Q3 Earnings and Revenues Beat Estimates
Merck (MRK) came out with quarterly earnings of $2.13 per share, beating the Zacks Consensus Estimate of $1.94 per share. This compares to earnings of more_horizontal
![Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth](https://cdn.snapi.dev/images/v1/l/w/107227287-1681843820437-gettyimages-1251953331-merck-prometheus-2122116.jpeg)
By CNBC
October 26, 2023
Merck results beat expectations on strong Keytruda, Gardasil and Covid drug growth
Merck's revenue and earnings beat expectations, and it hiked its sales forecast while lowering its profit outlook. more_horizontal
![Merck 3rd-quarter profit tops expectations on COVID pill surprise Merck 3rd-quarter profit tops expectations on COVID pill surprise](https://cdn.snapi.dev/images/v1/s/g/nq36tpcgojlevfm23nzlmn4piq-2122124.jpg)
By Reuters
October 26, 2023
Merck 3rd-quarter profit tops expectations on COVID pill surprise
Merck & Co on Thursday reported higher-than-expected third-quarter sales and profit on surprisingly strong demand for its COVID-19 treatment, primaril more_horizontal